AG
AMPE

Advisor Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Advisor Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$47K Buy
267
+30
+13% +$3.88K ﹤0.01% 3465
2019
Q3 		$36K Buy
237
+25
+12% +$3.33K ﹤0.01% 3617
2019
Q2 		$24K Hold
212
– – ﹤0.01% 3880
2019
Q1 		$36K Hold
212
– – ﹤0.01% 3614
2018
Q4 		$25K Buy
212
+46
+28% +$7.06K ﹤0.01% 3669
2018
Q3 		$26K Buy
166
+30
+22% +$12.5K ﹤0.01% 3735
2018
Q2 		$90K Sell
136
-14
-9% -$10.5K ﹤0.01% 2607
2018
Q1 		$153K Hold
150
– – ﹤0.01% 2192
2017
Q4 		$183K Sell
150
-16
-10% -$7.52K ﹤0.01% 2070
2017
Q3 		$30K Buy
166
+47
+39% +$7.44K ﹤0.01% 3322
2017
Q2 		$19K Buy
119
+33
+38% +$6.67K ﹤0.01% 3537
2017
Q1 		$21K Hold
86
– – ﹤0.01% 3356
2016
Q4 		$23K Hold
86
– – ﹤0.01% 3145
2016
Q3 		$19K Hold
86
– – ﹤0.01% 3191
2016
Q2 		$33K Buy
+86
New +$93.9K ﹤0.01% 2727

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Advisor Group's AMPE Position: Q4 2019 in Review

Advisor Group increased its Ampio Pharmaceuticals Inc. (AMPE) stake by 13% in Q4 2019, buying an estimated $3.88K and bringing the position to 267 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #3465.

Advisor Group first reported a position in AMPE in Q2 2016 and has held it in 15 quarters since. The position peaked at $183K in Q4 2017. 76 funds tracked by Wall St. Rank hold AMPE as of Q4 2019.

  • Advisor Group held 267 shares of Ampio Pharmaceuticals Inc. worth $47K as of Q4 2019.
  • Advisor Group bought 30 Ampio Pharmaceuticals Inc. shares in Q4 2019, an estimated $3.88K.
  • Ampio Pharmaceuticals Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3465 holding.
  • Advisor Group first reported a position in Ampio Pharmaceuticals Inc. in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Ampio Pharmaceuticals Inc. position peaked at $183K in Q4 2017.
  • 76 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.